Curis
CRIS
#11190
Rank
โ‚น0.15 B
Marketcap
โ‚น64.96
Share price
-5.38%
Change (1 day)
-51.85%
Change (1 year)

Curis (CRIS) - Total debt

Total debt on the balance sheet as of June 2026 : โ‚น0.10 Billion

According to Curis's latest financial reports the company's total debt is โ‚น0.10 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Curis - Total debt on balance sheet (from 2000 to 2026)

Total debt by year

Year Total debt Change
2025-12-31โ‚น0.14 B-42.68%
2024-12-31โ‚น0.25 B8.95%
2023-12-31โ‚น0.23 B-28.68%
2022-12-31โ‚น0.32 B-13.07%
2021-12-31โ‚น0.37 B-33.05%
2020-12-31โ‚น0.56 B4633.66%
2019-12-31โ‚น11.83 M-99.52%
2018-12-31โ‚น2.48 B-6.49%
2017-12-31โ‚น2.65 B96.6%
2016-12-31โ‚น1.34 B-15.96%
2015-12-31โ‚น1.60 B-10.46%
2014-12-31โ‚น1.79 B-4.99%
2013-12-31โ‚น1.88 B15.54%
2012-12-31โ‚น1.63 B
2008-12-31N/A-100%
2007-12-31โ‚น15.84 M-81.92%
2006-12-31โ‚น87.67 M-66.59%
2005-12-31โ‚น0.26 B-11.55%
2004-12-31โ‚น0.29 B15.21%
2003-12-31โ‚น0.25 B-56.74%
2002-12-31โ‚น0.59 B16.76%
2001-12-31โ‚น0.50 B78.32%
2000-12-31โ‚น0.28 B384.82%
1999-12-31โ‚น58.98 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
โ‚น6.115 T 6,052,965.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น4.360 T 4,315,321.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
โ‚น2.79 B 2,662.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚น16.05 B 15,793.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น0.47 B 369.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
โ‚น0.76 B 656.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น56.30 B 55,627.97%๐Ÿ‡บ๐Ÿ‡ธ USA